CEVA Inc
CEVA
33.49
-0.17
-0.51%
CEVA Inc
US · CEVA
#3253 by market cap
33.49
-0.17
-0.51%
Live - 5344 symbols - heartbeat 96s ago
· 2026-10-09 19:30
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 11.90, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.49% YoY
Margins
- Gross margin
- 87.08%
- Operating margin
- -10.35%
- Net margin
- -9.71%
Key ratios & quality
- Altman Z-Scorei
- 11.90
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 77.88M | 87.15M | 100.33M | 113.83M | 120.58M | 97.42M | 106.94M | 109.60M |
| Gross profit | 69.93M | 77.05M | 89.58M | 103.45M | 105.45M | 85.77M | 94.17M | 95.44M |
| Selling & admin expenses | 22.52M | 24.20M | 26.02M | 25.02M | 25.66M | 25.96M | 29.50M | 31.36M |
| Research & development | 47.76M | 52.84M | 62.01M | 69.09M | 70.32M | 72.69M | 71.62M | 74.83M |
| Operating profit | -1.25M | -1.92M | -763.00K | 7.04M | 7.45M | -13.47M | -7.55M | -11.35M |
| Pretax profit | 1.30M | 1.37M | 2.52M | 9.22M | 4.20M | -8.21M | -2.76M | -4.69M |
| Tax | 729.00K | 1.34M | 4.90M | 6.82M | 18.08M | 10.23M | 6.03M | 5.95M |
| Net profit | 574.00K | 28.00K | -2.38M | 396.00K | -23.18M | -11.88M | -8.79M | -10.64M |
| Basic EPS | 0 | 0 | 0 | 0 | -1 | -1 | 0 | 0 |
| Diluted EPS | 0.03 | 0.00 | -0.11 | 0.02 | -0.60 | -0.51 | -0.37 | -0.44 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 24.25M | 25.68M | 28.38M | 31.29M | 27.02M | 29.03M |
| Gross profit | 20.76M | 22.13M | 24.99M | 27.56M | 23.30M | 25.39M |
| Selling & admin expenses | 7.38M | 7.70M | 7.40M | 8.88M | 8.43M | 8.02M |
| Research & development | 17.61M | 18.76M | 19.53M | 18.93M | 19.84M | 19.33M |
| Operating profit | -4.38M | -4.48M | -2.08M | -398.00K | -5.09M | -2.08M |
| Pretax profit | -2.34M | -2.57M | -838.00K | 1.05M | -3.14M | -1.07M |
| Tax | 991.00K | 1.14M | 1.67M | 2.15M | 1.32M | 1.84M |
| Net profit | -3.33M | -3.70M | -2.51M | -1.10M | -4.46M | -2.91M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.14 | -0.15 | -0.10 | -0.04 | -0.16 | -0.10 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 177.29M | 178.55M | 167.56M | 188.98M | 177.63M | 209.37M | 216.34M | 284.84M |
| Cash & ST investments | 145.87M | 144.59M | 130.13M | 154.86M | 138.31M | 166.54M | 163.64M | 221.98M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 277.26M | 297.02M | 306.95M | 328.66M | 308.44M | 304.09M | 308.95M | 388.26M |
| Total current liabilities | 21.75M | 26.38M | 28.18M | 35.44M | 33.28M | 26.89M | 30.53M | 28.68M |
| Short-term debt | -- | 2.39M | 2.97M | 3.27M | 2.68M | 2.51M | 2.60M | 1.74M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 31,384,000.00 | 45,864,000.00 | 46,063,000.00 | 51,927,000.00 | 49,571,000.00 | 39,744,000.00 | 42,392,000.00 | 51,798,000.00 |
| Total equity | 245.88M | 251.16M | 260.89M | 276.73M | 258.87M | 264.34M | 266.56M | 336.46M |
| Retained earnings | 62.85M | 62.43M | 57.35M | 55.49M | 32.16M | 20.17M | 11.19M | -24.00K |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 216.99M | 208.81M | 214.41M | 284.84M | 280.86M | 283.18M |
| Cash & ST investments | 158.35M | 157.50M | 152.06M | 221.98M | 215.69M | 220.72M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 309.99M | 302.84M | 306.01M | 388.26M | 388.23M | 391.89M |
| Total current liabilities | 29.13M | 24.34M | 24.71M | 28.68M | 27.37M | 27.98M |
| Short-term debt | 2.00M | 1.61M | 1.24M | 1.74M | 2.79M | 2.66M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 40,859,000.00 | 36,950,000.00 | 37,295,000.00 | 51,798,000.00 | 50,043,000.00 | 51,644,000.00 |
| Total equity | 269.13M | 265.89M | 268.72M | 336.46M | 338.18M | 340.25M |
| Retained earnings | 7.36M | 3.66M | 1.10M | -24.00K | -4.48M | -7.39M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 8.61M | 9.67M | 15.16M | 25.80M | 6.92M | -6.33M | 3.47M | -3.36M |
| Depreciation & amortization | 4.16M | 5.27M | 5.82M | 6.99M | 7.56M | 4.88M | 4.14M | 4.27M |
| Free cash flow | 3.33M | -1.15M | 12.23M | 23.61M | 3.43M | -9.22M | 516.00K | -6.28M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -20.01M | -9.11M | -4.78M | 0 | -6.79M | -6.16M | -8.46M | 56.11M |
| Ending cash balance | 22.26M | 22.80M | 21.14M | 33.15M | 21.29M | 23.29M | 18.50M | 40.59M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -7.40M | 1.18M | -5.86M | 8.72M | -4.89M | 5.83M |
| Depreciation & amortization | 859.00K | 1.11M | 1.16M | 1.15M | 861.00K | 801.00K |
| Free cash flow | -7.72M | 492.00K | -6.29M | 7.23M | -7.20M | 5.19M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -988.00K | 63.26M | -- | -- |
| Ending cash balance | 18.81M | 29.08M | 17.27M | 40.59M | 21.37M | 44.30M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 0.23 | 0.01 | -0.93 | 0.15 | -8.66 | -4.54 | -3.31 | -3.53 |
| ROA %i | 0.21 | 0.01 | -0.79 | 0.12 | -7.28 | -3.88 | -2.87 | -3.05 |
| ROIC %i | -0.87 | -1.02 | -1.68 | -0.24 | -9.17 | -5.72 | -4.95 | -4.99 |
| 5-year avg ROE %i | 3.46 | 3.55 | 2.67 | 1.39 | -1.84 | -2.79 | -3.46 | -3.98 |
| EBIT margin %i | 2.67 | 2.20 | 2.96 | 4.98 | -3.50 | -13.82 | -7.06 | -10.35 |
| FCF / sales %i | 4.28 | -- | 12.19 | 19.24 | 2.54 | -- | 0.48 | -- |
| Current ratioi | 8.15 | 6.77 | 5.95 | 5.33 | 5.34 | 7.79 | 7.09 | 9.93 |
| Quick ratioi | 7.91 | 6.55 | 5.73 | 5.14 | 5.05 | 7.32 | 6.58 | 9.46 |
| Debt / assetsi | 0.00 | 3.59 | 2.85 | 2.56 | 2.56 | 2.12 | 1.80 | 4.15 |
| LT debt / equityi | -- | 3.29 | 2.21 | 1.85 | 2.01 | 1.49 | 1.11 | 4.28 |
| Interest coveragei | 2.69 | 3.47 | 6.68 | 14.54 | -11.87 | -- | -- | -- |
| Revenue CAGR (3Y) %i | 9.39 | 6.25 | 4.66 | 13.49 | 11.43 | -0.98 | -2.06 | -3.13 |
| Net income CAGR (3Y) %i | -54.92 | -87.12 | -- | -11.64 | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -42.13 | -- | -15.59 | 92.06 | -- | -- | -72.04 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -2.51 | -3.81 | -4.22 | -3.53 | -3.88 | -3.62 |
| ROA %i | -2.18 | -3.34 | -3.69 | -3.05 | -3.37 | -3.16 |
| ROIC %i | -4.18 | -5.48 | -5.89 | -4.99 | -5.04 | -4.89 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -6.39 | -10.73 | -10.11 | -10.35 | -10.72 | -8.33 |
| FCF / sales %i | 0.97 | -- | -- | -- | -- | -- |
| Current ratioi | 7.45 | 8.58 | 8.68 | 9.93 | 10.26 | 10.12 |
| Quick ratioi | 6.84 | 7.98 | 8.17 | 9.46 | 9.66 | 9.56 |
| Debt / assetsi | 1.56 | 1.44 | 1.23 | 4.15 | 4.35 | 4.45 |
| LT debt / equityi | 1.05 | 1.04 | 0.95 | 4.28 | 4.16 | 4.34 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Licensing of intellectual property (IP) to semiconductor companies and electronic equipment100.00%
Region
China61.95%
United States17.60%
Asia Pacific14.73%
Europe and Middle East5.73%
Quote time 2026-10-09 19:30:06 · For reference only, not investment advice and not tailored to your situation.
CEVA Inc discussion 0 comments